Fallopian tube cancer (FTC) is one of the most rare malignancies of the female reproductive system, accounting for only 0.14%-1.8% of all gynecologic cancers. Its rarity contributes to the difficulty in making a definite diagnosis and determining its prognosis, and its diagnosis is rarely done preoperatively. The presence of a hydrosalpinx is a hallmark of FTC. Here, we report three cases of FTC to explore an approach for its diagnosis and management. Because FTC shares similar clinical findings with ovarian carcinoma, it is often diagnosed intraoperatively. The elevation of serum CA125 levels contributes to the diagnosis of FTC. Surgical cytoreduction followed by chemotherapy is the best therapeutic option for FTC.
|Title of host publication||Obstetric and Gynecology Case Report|
|Publisher||Nova Science Publishers, Inc.|
|Number of pages||10|
|Publication status||Published - 1 Jan 2020|
- Fallopian tube cancer